Filing Details
AbbVie Inc. (NYSE:ABBV) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 03, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNYSE:ABBV
AbbVie Inc. (ABBV) Files Quarterly Report for Q0
Filing Details AbbVie Inc. (NYSE:ABBV) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 03, 2026. The Healthcare company reported Q0…
Market Context
AbbVie Inc.'s stock currently trades at $245.08 with a market capitalization of $410.1B.
The 10-Q provides AbbVie Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for AbbVie Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View ABBV Stock Page
Frequently Asked Questions
Where can I read ABBV's SEC filings?
Browse all filings on our ABBV SEC filings page.
What types of SEC filings does AbbVie Inc. file?
Public companies like AbbVie Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.